| Title |
COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects First, Do No Harm
|
|---|---|
| Published in |
JACC, May 2020
|
| DOI | 10.1016/j.jacc.2020.05.008 |
| Pubmed ID | |
| Authors |
Michael H. Gollob |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Argentina | 3 | 20% |
| Japan | 2 | 13% |
| United States | 1 | 7% |
| France | 1 | 7% |
| Brazil | 1 | 7% |
| Ireland | 1 | 7% |
| United Kingdom | 1 | 7% |
| Ecuador | 1 | 7% |
| Unknown | 4 | 27% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 73% |
| Science communicators (journalists, bloggers, editors) | 2 | 13% |
| Practitioners (doctors, other healthcare professionals) | 2 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 103 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 14 | 14% |
| Researcher | 11 | 11% |
| Student > Doctoral Student | 8 | 8% |
| Student > Ph. D. Student | 7 | 7% |
| Other | 6 | 6% |
| Other | 27 | 26% |
| Unknown | 30 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 38 | 37% |
| Biochemistry, Genetics and Molecular Biology | 6 | 6% |
| Nursing and Health Professions | 4 | 4% |
| Engineering | 4 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Other | 13 | 13% |
| Unknown | 35 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 August 2020.
All research outputs
#1,319,460
of 25,387,668 outputs
Outputs from JACC
#3,142
of 16,743 outputs
Outputs of similar age
#38,431
of 418,685 outputs
Outputs of similar age from JACC
#90
of 242 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,743 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.0. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 418,685 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 242 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.